Gerald Cochran1, Adam J Gordon, Wei-Hsuan Lo-Ciganic, Walid F Gellad, Winfred Frazier, Carroline Lobo, Chung-Chou H Chang, Ping Zheng, Julie M Donohue. 1. *School of Social Work †Department of Psychiatry, School of Medicine ‡Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh §VA Pittsburgh Healthcare System ∥Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA ¶University of Arizona College of Pharmacy, Tucson, AZ #University of Pittsburgh Graduate School of Public Health **University of Pittsburgh School of Medicine, Pittsburgh, PA.
Abstract
BACKGROUND: Health systems may play an important role in identification of patients at-risk of opioid medication overdose. However, standard measures for identifying overdose risk in administrative data do not exist. OBJECTIVE: Examine the association between opioid medication overdose and 2 validated measures of nonmedical use of prescription opioids within claims data. RESEARCH DESIGN: A longitudinal retrospective cohort study that estimated associations between overdose and nonmedical use. SUBJECTS: Adult Pennsylvania Medicaid program 2007-2012 patients initiating opioid treatment who were: nondual eligible, without cancer diagnosis, and not in long-term care facilities or receiving hospice. MEASURES: Overdose (International Classification of Disease, ninth edition, prescription opioid poisonings codes), opioid abuse (opioid use disorder diagnosis while possessing an opioid prescription), opioid misuse (a composite indicator of number of opioid prescribers, number of pharmacies, and days supplied), and dose exposure during opioid treatment episodes. RESULTS: A total of 372,347 Medicaid enrollees with 583,013 new opioid treatment episodes were included in the cohort. Opioid overdose was higher among those with abuse (1.5%) compared with those without (0.2%, P<0.001). Overdose was higher among those with probable (1.8%) and possible (0.9%) misuse compared with those without (0.2%, P<0.001). Abuse [adjusted rate ratio (ARR), 1.52; 95% confidence interval (CI), 1.10-2.10), probable misuse (ARR, 1.98; 95% CI, 1.46-2.67), and possible misuse (ARR, 1.76; 95% CI, 1.48-2.09) were associated with significantly more events of opioid medication overdose compared with those without. CONCLUSIONS: Claims-based measures can be used by health systems to identify individuals at-risk of overdose who can be targeted for restrictions on opioid prescribing, dispensing, or referral to treatment.
BACKGROUND: Health systems may play an important role in identification of patients at-risk of opioid medication overdose. However, standard measures for identifying overdose risk in administrative data do not exist. OBJECTIVE: Examine the association between opioid medication overdose and 2 validated measures of nonmedical use of prescription opioids within claims data. RESEARCH DESIGN: A longitudinal retrospective cohort study that estimated associations between overdose and nonmedical use. SUBJECTS: Adult Pennsylvania Medicaid program 2007-2012 patients initiating opioid treatment who were: nondual eligible, without cancer diagnosis, and not in long-term care facilities or receiving hospice. MEASURES: Overdose (International Classification of Disease, ninth edition, prescription opioid poisonings codes), opioid abuse (opioid use disorder diagnosis while possessing an opioid prescription), opioid misuse (a composite indicator of number of opioid prescribers, number of pharmacies, and days supplied), and dose exposure during opioid treatment episodes. RESULTS: A total of 372,347 Medicaid enrollees with 583,013 new opioid treatment episodes were included in the cohort. Opioid overdose was higher among those with abuse (1.5%) compared with those without (0.2%, P<0.001). Overdose was higher among those with probable (1.8%) and possible (0.9%) misuse compared with those without (0.2%, P<0.001). Abuse [adjusted rate ratio (ARR), 1.52; 95% confidence interval (CI), 1.10-2.10), probable misuse (ARR, 1.98; 95% CI, 1.46-2.67), and possible misuse (ARR, 1.76; 95% CI, 1.48-2.09) were associated with significantly more events of opioid medication overdose compared with those without. CONCLUSIONS: Claims-based measures can be used by health systems to identify individuals at-risk of overdose who can be targeted for restrictions on opioid prescribing, dispensing, or referral to treatment.
Authors: Teryl K Nuckols; Laura Anderson; Ioana Popescu; Allison L Diamant; Brian Doyle; Paul Di Capua; Roger Chou Journal: Ann Intern Med Date: 2014-01-07 Impact factor: 25.391
Authors: Meera Viswanathan; Leila C Kahwati; Carol E Golin; Susan J Blalock; Emmanuel Coker-Schwimmer; Rachael Posey; Kathleen N Lohr Journal: JAMA Intern Med Date: 2015-01 Impact factor: 21.873
Authors: Lynn R Webster; Susan Cochella; Nabarun Dasgupta; Keri L Fakata; Perry G Fine; Scott M Fishman; Todd Grey; Erin M Johnson; Lewis K Lee; Steven D Passik; John Peppin; Christina A Porucznik; Albert Ray; Sidney H Schnoll; Richard L Stieg; Wayne Wakeland Journal: Pain Med Date: 2011-06 Impact factor: 3.750
Authors: Adam J Rose; Dana Bernson; Kenneth Kwan Ho Chui; Thomas Land; Alexander Y Walley; Marc R LaRochelle; Bradley D Stein; Thomas J Stopka Journal: J Gen Intern Med Date: 2018-06-14 Impact factor: 5.128
Authors: Adeleke D Adewumi; Samantha A Hollingworth; Joemer C Maravilla; Jason P Connor; Rosa Alati Journal: CNS Drugs Date: 2018-02 Impact factor: 5.749
Authors: Adam J Rose; Ryan McBain; Megan S Schuler; Marc R LaRochelle; David A Ganz; Vikram Kilambi; Bradley D Stein; Dana Bernson; Kenneth Kwan Ho Chui; Thomas Land; Alexander Y Walley; Thomas J Stopka Journal: J Am Geriatr Soc Date: 2018-11-24 Impact factor: 5.562
Authors: Jason M Glanz; Komal J Narwaney; Shane R Mueller; Edward M Gardner; Susan L Calcaterra; Stanley Xu; Kristin Breslin; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2018-01-29 Impact factor: 5.128